Literature DB >> 25127083

Peptide YY and ghrelin predict craving and risk for relapse in abstinent smokers.

Mustafa al'Absi1, Andrine Lemieux2, Motohiro Nakajima3.   

Abstract

Appetite hormones are directly involved in regulating satiety, energy expenditure, and food intake, and accumulating evidence suggests their involvement in regulating reward and craving for drugs. This study investigated the ability of peptide YY (PYY) and ghrelin during the initial 24-48 h of a smoking cessation attempt to predict smoking relapse at 4 weeks. Multiple regression analysis indicated that increased PYY was associated with decreased reported craving and increased positive affect. Cox proportional hazard models showed that higher ghrelin levels predicted increased risk of smoking relapse (hazard ratio=2.06, 95% CI=1.30-3.27). These results indicate that circulating PYY may have buffering effects during the early stages of cessation while ghrelin may confer increased risk of smoking relapse. Further investigation of the links between these hormones and nicotine dependence is warranted.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Craving; Ghrelin; Nicotine dependence; Peptide YY; Relapse; Withdrawal

Mesh:

Substances:

Year:  2014        PMID: 25127083      PMCID: PMC4165731          DOI: 10.1016/j.psyneuen.2014.07.018

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  45 in total

1.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.

Authors:  L S Cox; S T Tiffany; A G Christen
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

2.  Differentiation in the short- and long-term effects of smoking on plasma total ghrelin concentrations between male nonsmokers and habitual smokers.

Authors:  Alexander Kokkinos; Nicholas Tentolouris; Evgenia Kyriakaki; Georgia Argyrakopoulou; John Doupis; Michael Psallas; Despoina Kyriaki; Nicholas Katsilambros
Journal:  Metabolism       Date:  2007-04       Impact factor: 8.694

3.  Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite.

Authors:  Alfonso Abizaid; Zhong-Wu Liu; Zane B Andrews; Marya Shanabrough; Erzsebet Borok; John D Elsworth; Robert H Roth; Mark W Sleeman; Marina R Picciotto; Matthias H Tschöp; Xiao-Bing Gao; Tamas L Horvath
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

Review 4.  The role of the central ghrelin system in reward from food and chemical drugs.

Authors:  Suzanne L Dickson; Emil Egecioglu; Sara Landgren; Karolina P Skibicka; Jörgen A Engel; Elisabet Jerlhag
Journal:  Mol Cell Endocrinol       Date:  2011-02-24       Impact factor: 4.102

5.  The association of the appetitive peptide acetylated ghrelin with alcohol craving in early abstinent alcohol dependent individuals.

Authors:  Anne Koopmann; Christoph von der Goltz; Martin Grosshans; Christina Dinter; Meike Vitale; Klaus Wiedemann; Falk Kiefer
Journal:  Psychoneuroendocrinology       Date:  2011-12-14       Impact factor: 4.905

6.  Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract.

Authors:  Ichiro Sakata; Kazuaki Nakamura; Mami Yamazaki; Maki Matsubara; Yuijiro Hayashi; Kenji Kangawa; Takafumi Sakai
Journal:  Peptides       Date:  2002-03       Impact factor: 3.750

7.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

8.  Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

Authors:  B G Challis; A P Coll; G S H Yeo; S B Pinnock; S L Dickson; R R Thresher; J Dixon; D Zahn; J J Rochford; A White; R L Oliver; G Millington; S A Aparicio; W H Colledge; A P Russ; M B Carlton; S O'Rahilly
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

9.  The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress.

Authors:  Michael Lutter; Ichiro Sakata; Sherri Osborne-Lawrence; Sherry A Rovinsky; Jason G Anderson; Saendy Jung; Shari Birnbaum; Masashi Yanagisawa; Joel K Elmquist; Eric J Nestler; Jeffrey M Zigman
Journal:  Nat Neurosci       Date:  2008-06-15       Impact factor: 24.884

10.  Genetic variation of the ghrelin signalling system in individuals with amphetamine dependence.

Authors:  Petra Suchankova; Elisabet Jerlhag; Nitya Jayaram-Lindström; Staffan Nilsson; Kjell Toren; Annika Rosengren; Jörgen A Engel; Johan Franck
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more
  19 in total

1.  Changes in circulating leptin levels during the initial stage of cessation are associated with smoking relapse.

Authors:  Andrine Lemieux; Motohiro Nakajima; Dorothy K Hatsukami; Sharon Allen; Mustafa al'Absi
Journal:  Psychopharmacology (Berl)       Date:  2015-07-10       Impact factor: 4.530

Review 2.  Khat use and appetite: an overview and comparison of amphetamine, khat and cathinone.

Authors:  Andrine M Lemieux; Bingshuo Li; Mustafa al'Absi
Journal:  J Ethnopharmacol       Date:  2014-11-28       Impact factor: 4.360

3.  Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse.

Authors:  Mustafa al'Absi; Andrine Lemieux; James S Hodges; Sharon Allen
Journal:  Addict Biol       Date:  2018-08-16       Impact factor: 4.280

Review 4.  The dopamine motive system: implications for drug and food addiction.

Authors:  Nora D Volkow; Roy A Wise; Ruben Baler
Journal:  Nat Rev Neurosci       Date:  2017-11-16       Impact factor: 34.870

Review 5.  Stress and Addiction: When a Robust Stress Response Indicates Resiliency.

Authors:  Mustafa alʼAbsi
Journal:  Psychosom Med       Date:  2018-01       Impact factor: 4.312

Review 6.  Pharmacological Effects and Regulatory Mechanisms of Tobacco Smoking Effects on Food Intake and Weight Control.

Authors:  Tongyuan Hu; Zhongli Yang; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2018-07-27       Impact factor: 4.147

7.  Changes in circulating peptide YY and ghrelin are associated with early smoking relapse.

Authors:  Andrine M Lemieux; Mustafa al'Absi
Journal:  Biol Psychol       Date:  2017-03-12       Impact factor: 3.251

8.  Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses.

Authors:  Sofia Bouhlal; Kayla N Ellefsen; Mikela B Sheskier; Erick Singley; Sandrine Pirard; David A Gorelick; Marilyn A Huestis; Lorenzo Leggio
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

9.  Desacylghrelin but not acylghrelin is reduced during smoking cessation.

Authors:  Mahsa Ardeshiripur; Mathias Rhein; Helge Frieling; Stefan Bleich; Thomas Hillemacher; Marc Muschler; Alexander Glahn
Journal:  J Neural Transm (Vienna)       Date:  2018-09-24       Impact factor: 3.575

Review 10.  Medications for alcohol use disorders: An overview.

Authors:  Mohammed Akbar; Mark Egli; Young-Eun Cho; Byoung-Joon Song; Antonio Noronha
Journal:  Pharmacol Ther       Date:  2017-12-02       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.